2 May 2014 Last updated at 08:09 US drugs giant Pfizer has raised the price it is offering for UK firm AstraZeneca to £50 a share, valuing the firm at £63bn. Pfizer’s initial offer in January was a combination of cash and shares worth £46.61 per AstraZeneca share, which…
Source:Pfizer raises AstraZeneca bid
Friday, May 2, 2014
Pfizer raises AstraZeneca bid
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment